GB0307862D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB0307862D0
GB0307862D0 GBGB0307862.3A GB0307862A GB0307862D0 GB 0307862 D0 GB0307862 D0 GB 0307862D0 GB 0307862 A GB0307862 A GB 0307862A GB 0307862 D0 GB0307862 D0 GB 0307862D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0307862.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0307862.3A priority Critical patent/GB0307862D0/en
Publication of GB0307862D0 publication Critical patent/GB0307862D0/en
Priority to CNA2004800092489A priority patent/CN1771035A/zh
Priority to EP04725330A priority patent/EP1613316A1/en
Priority to BRPI0409190-6A priority patent/BRPI0409190A/pt
Priority to MXPA05010700A priority patent/MXPA05010700A/es
Priority to US10/550,359 priority patent/US20070117764A1/en
Priority to PCT/EP2004/003510 priority patent/WO2004087143A1/en
Priority to CA002521260A priority patent/CA2521260A1/en
Priority to YUP-2005/0731A priority patent/RS20050731A/sr
Priority to JP2006504963A priority patent/JP2006522056A/ja
Priority to AU2004226818A priority patent/AU2004226818A1/en
Priority to IS8104A priority patent/IS8104A/is
Priority to NO20055180A priority patent/NO20055180L/no
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0307862.3A 2003-04-04 2003-04-04 Pharmaceutical composition Ceased GB0307862D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB0307862.3A GB0307862D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
AU2004226818A AU2004226818A1 (en) 2003-04-04 2004-04-02 Compositions comprising macrolide T-cell immunomodulators or immunosuppressants in combination with antibacterials
PCT/EP2004/003510 WO2004087143A1 (en) 2003-04-04 2004-04-02 Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials
EP04725330A EP1613316A1 (en) 2003-04-04 2004-04-02 Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials
BRPI0409190-6A BRPI0409190A (pt) 2003-04-04 2004-04-02 composições compreendendo macrolìdeos imunomoduladores ou imonossupressores de célula t em combinação com agentes antibacterianos
MXPA05010700A MXPA05010700A (es) 2003-04-04 2004-04-02 Composiciones que comprenden inmunosupresores o inmunomoduladores de celula t de macrolido en combinacion con antibacterianos.
US10/550,359 US20070117764A1 (en) 2003-04-04 2004-04-02 Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials
CNA2004800092489A CN1771035A (zh) 2003-04-04 2004-04-02 包含大环内酯类t－细胞免疫调节剂或免疫抑制剂和抗菌剂的组合物
CA002521260A CA2521260A1 (en) 2003-04-04 2004-04-02 Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials
YUP-2005/0731A RS20050731A (sr) 2003-04-04 2004-04-02 Kompozicije koje obuhvataju imunomodulatore ili imunosupresore t-ćelija u kombinaciji sa antibakterijskim sredstvima
JP2006504963A JP2006522056A (ja) 2003-04-04 2004-04-02 抗菌剤と組合せたマクロライド系ｔ細胞免疫調節剤または免疫抑制剤を含んでなる組成物
IS8104A IS8104A (is) 2003-04-04 2005-10-31 Blöndur sem fela í sér ónæmisbreyta eða ónæmisbæla makrólíðs T-frumu í samsetningu við bakteríueyðandi efni
NO20055180A NO20055180L (no) 2003-04-04 2005-11-03 Sammensetninger som innbefatter makrolid T-celle immunomodulerende eller -immunosupressive stoffer i kombinasjon med antibakterielle stoffer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0307862.3A GB0307862D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB0307862D0 true GB0307862D0 (en) 2003-05-14

Family

ID=9956225

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0307862.3A Ceased GB0307862D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition

Country Status (13)

Country Link
US (1) US20070117764A1 (https=)
EP (1) EP1613316A1 (https=)
JP (1) JP2006522056A (https=)
CN (1) CN1771035A (https=)
AU (1) AU2004226818A1 (https=)
BR (1) BRPI0409190A (https=)
CA (1) CA2521260A1 (https=)
GB (1) GB0307862D0 (https=)
IS (1) IS8104A (https=)
MX (1) MXPA05010700A (https=)
NO (1) NO20055180L (https=)
RS (1) RS20050731A (https=)
WO (1) WO2004087143A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307864D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
CN101711869B (zh) * 2009-09-23 2012-04-04 王国礼 喹诺酮类抗菌药物在银屑病治疗中的应用
JP7446594B2 (ja) * 2017-07-21 2024-03-11 学校法人東京薬科大学 好中球細胞外トラップ形成促進剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0209474A (pt) * 2001-05-09 2006-02-07 Novartis Ag Métodos para imunomodulação seletiva
US20030021816A1 (en) * 2001-06-06 2003-01-30 Sewon Kang Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
WO2003004098A1 (en) * 2001-07-06 2003-01-16 Sucampo Ag Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent
US20030207819A1 (en) * 2002-05-02 2003-11-06 Moskowitz Roland W. Compositions and methods for treating inflammatory connective tissue diseases

Also Published As

Publication number Publication date
US20070117764A1 (en) 2007-05-24
NO20055180L (no) 2006-01-04
WO2004087143A1 (en) 2004-10-14
JP2006522056A (ja) 2006-09-28
BRPI0409190A (pt) 2006-04-11
IS8104A (is) 2005-10-31
CA2521260A1 (en) 2004-10-14
NO20055180D0 (no) 2005-11-03
CN1771035A (zh) 2006-05-10
RS20050731A (sr) 2007-11-15
MXPA05010700A (es) 2005-12-12
AU2004226818A1 (en) 2004-10-14
EP1613316A1 (en) 2006-01-11

Similar Documents

Publication Publication Date Title
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
AU2003291103A8 (en) Pharmaceutical composition
GB0300427D0 (en) Pharmaceutical composition
IL164547A0 (en) Pharmaceutical composition
HU0301154D0 (en) Pharmaceutical composition
AU2003250372A8 (en) Pharmaceutical composition
GB0300531D0 (en) Pharmaceutical compositions
EP1648411A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) PHARMACEUTICAL COMPOSITION
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
ZA200605080B (en) Pharmaceutical compositions
GB0300885D0 (en) Pharmaceutical composition
EP1600445A4 (en) CURATIVE PREPARATION
EP1655029A4 (en) MEDICINAL COMPOSITIONS
GB0306933D0 (en) Pharmaceutical composition
GB0307869D0 (en) Pharmaceutical composition
GB0305579D0 (en) Pharmaceutical compositions
GB0307864D0 (en) Pharmaceutical composition
GB0307867D0 (en) Pharmaceutical composition
GB0307862D0 (en) Pharmaceutical composition
GB0217703D0 (en) Pharmaceutical composition
GB0307865D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)